MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Argos Therapeutics Company Profile (NASDAQ:ARGS)

Consensus Ratings for Argos Therapeutics (NASDAQ:ARGS) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.25 (158.23% upside)

Analysts' Ratings History for Argos Therapeutics (NASDAQ:ARGS)
Show:
DateFirmActionRatingPrice TargetActions
6/26/2015FBR & Co.Initiated CoverageOutperform$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015MLV & Co.Set Price TargetBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Roth CapitalReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2015MLV & Co.Reiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015MLV & Co.Reiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Roth CapitalInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015MLV & Co.Initiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Stifel NicolausInitiated CoverageBuy -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Piper JaffrayInitiated CoverageOverweight$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014JMP SecuritiesInitiated CoverageOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Needham & Company LLCInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/6/2013 forward)